The global bone densitometer devices market is poised for significant growth, with an estimated value of USD 347.7 million in 2023 and a projected increase to USD 525.0 million by 2033. This growth represents a compound annual growth rate (CAGR) of 4.2% over the forecast period from 2023 to 2033.
Bone densitometer devices play a crucial role in diagnosing and managing bone-related diseases by performing non-invasive procedures to assess bone density and strength. These devices are essential for detecting conditions such as osteoporosis and for evaluating the risk of fractures, thereby aiding in early diagnosis and effective management of bone health.
As awareness of bone health issues rises, so does the demand for accurate and reliable diagnostic tools. Bone densitometers are increasingly used in both clinical and research settings to monitor bone health, especially in populations at higher risk for bone density loss.
Bone densitometers also analyze the risk of developing bone disorders. One of the major market drivers for bone densitometer devices is the rising incidences of knee osteoarthritis. With over 203 knee osteoarthritis cases for every 10,000 persons, 20 years of age and above, bone densitometer devices are expected to be in high demand in the upcoming years.
Moreover, a surge in favorable reimbursement policies by Medicare will likely spur the demand for bone densitometer devices, particularly in countries like India and the U.S. Medicare provides private health insurance plans for the treatment of osteoporosis, which in turn accounts for the increasing expansion of the bone densitometer devices market. Also, many manufacturers are keen on releasing innovative products with novel offerings like low dosage and patented narrow-fan beam technology.
This factor coupled with the rising need for excellent precision and accuracy, high-definition image quality, and faster scans for multiple clinical applications will foster an atmosphere of growth for the target over the projected period.
“Growing bone health awareness, more widespread knowledge about osteoporosis along with initiatives from NGOs and government organizations will likely drive the market growth for the bone densitometer devices over the forecast period,” says an FMI analyst.
Bone Densitometer Devices Market Key Takeaways:
- Heightened demand for precise, speedy, and high-quality diagnosis to strengthen the market prospects.
- The high cost of the target product and limitations of the DXA technology of bone densitometer devices will impede the market growth.
- The U.S. will dominate the global market space with a CAGR of 4.9%.
- The market in Germany will be driven by increasing bone disorder awareness programs.
- Axial bone densitometer segment will grow at a CAGR of 4.2%
- In terms of technology, Dual Energy X-ray absorptiometry will hold about 3/5th of total revenue.
Bone Densitometer Devices Market Competitive Landscape
GE Healthcare, Hologic, Inc., OSI Systems, Inc., Diagnostic Medical Systems Group, Swissray Global Healthcare Holding, Ltd., BeamMed, Ltd., Echolight S.P.A, Scanflex Healthcare AB, Medonica Co., Ltd., XinGaoYi Co., Ltd., Anjue Medical Equipment, Trivitron Healthcare, Eurotec Systems S.r.l, AMPall Co., Ltd., L’acn L’accessorio Nucleare S.R.L, Shenzhen XRAY Electric Co., Ltd., YOZMA BMTech Co., Ltd., Nanoomtech Co., Ltd., Osteosys Corporation, FURUNO Electric Co., Ltd ., and others are some of the major players in the bone densitometer devices market profiled in the full version of the report.
Leading market players are concentrating on improving their product features to expand their business and enter new markets. Strategies like mergers, acquisitions, and distribution agreements are also employed by these enterprises to strengthen their position in the bone densitometer devices market.
A Full Report – Overview
Bone Densitometer Devices Market by Category
By Product:
- Peripheral Bone Densitometer
- Axial Bone Densitometer
By Technology:
- Dual Energy X-ray absorptiometry (DXA)
- Peripheral Dual Energy X-Ray
- Absorptiometry (pDXA)
- Quantitative Ultrasound (QUS)
- Others
By End-User:
- Hospitals
- Orthopedic Clinics
- Diagnostic Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube